Medical Devices
E-QURE / Lifewave
An innovative treatment device for the complete closure and treatment of pressure ulcers. A comprehensive clinical study in 60 medical centers has proven efficacy in full wound closure within 40 days of treatment. The device received FDA approval and recognition in the international medical community as an effective solution for chronic wound treatment. The developing company went public at a valuation of over $300 million.
Key Features
- Full closure and treatment of pressure ulcers
- Clinically tested in 60 medical centers
- FDA approved
- Company valuation of over $300 million in the stock market
THE NEXT CHAPTER STARTS WITH A CONVERSATION
Let’s develop what’s next.
We'd love to tell you more about our products, technological capabilities, and collaboration opportunities